共 101 条
[1]
Mayers D.L., Lerner S.A., Ouelette M., Et al., Antimicrobial Drug Resistance C: Clinical and Epidemiological Aspects, 2, pp. 681-1347, (2009)
[2]
Guschin A., Ryzhikh P., Rumyantseva T., Et al., Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with Josamycin, BMC Infect. Dis., 15, pp. 1-7, (2015)
[3]
Martin I., Sawatzky P., Liu G., Et al., Antimicrobial resistance to Neisseria gonorrhoeae in Canada: 2009-2013, Can. Commun. Dis. Rep., 41, pp. 40-41, (2015)
[4]
Berdy J., Bioactive microbial metabolites, J. Antibiot., 58, pp. 1-26, (2005)
[5]
Runyoro D.K., Matee M.I., Ngassapa O.D., Et al., Screening of Tanzanian medicinal plants for anti-Candida activity, BMC Complement. Altern. Med., 6, (2006)
[6]
Mabona U., Viljoen A., Shikanga E., Et al., Antimicrobial activity of Southern African medicinal plants with dermatological relevance: From an ethnopharmacological screening approach, to combination studies and the isolation of a bioactive compound, J. Ethnopharmacol., 148, pp. 45-55, (2013)
[7]
Nazzaro F., Fratianni F., De Martino L., Et al., Effect of essential oils on pathogenic bacteria, Pharmaceuticals, 6, pp. 1451-1474, (2013)
[8]
Heatley N.G., A method for the assay of penicillin, Biochem. J., 38, pp. 61-65, (1944)
[9]
CLSI, Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved Standard, CLSI Document M02-A11, (2012)
[10]
CLSI, Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts, Approved Guideline, CLSI Document M44-A, (2004)